Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection;Syndrome de Vogt-Koyanagi-Harada au cours d'une hépatite C chronique sous interféron alpha et ribavirine

Journal Francais d'Ophtalmologie

Volumn 33, Issue 3, 2010, Pages 185-188

  Chebil, A ^a   Kort, F ^a   Bouraoui, R ^a   Youssef, N Ben ^a   Matri, L El ^a  

^a Institut Hedi Rais d'Ophtalmologie   (Tunisia)

Author keywords

Autoimmunity; Hepatitis C; Vogt Koyanagi Harada

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RIBAVIRIN; TROPICAMIDE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HEPATITIS C; HUMAN; MALE; MENINGOENCEPHALITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2A; MALE; METHYLPREDNISOLONE; RIBAVIRIN; TROPICAMIDE; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 77949659594     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2010.01.009     Document Type: Article

References (12)

1. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-292
2. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000;15:7323-7329
3. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-652
4. Alaoui FZ, Benamour S, El Kabli H, Amraoui A. Vogt- Koyanagi-Harada syndrome: Eight cases. Rev Med Interne 2007;28:250-254
5. Blanc F, Fleury M, Talmant V, Deroide N, Szwarcberg J, Tranchant C. Le syndrome de Vogt-Koyanagi-Harada. Rev Neurol (Paris) 2005;161:1079-1090
6. Thomson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect 2005;11:86-94.
7. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994;101:736-745
8. Cacoub E, Benhamou Y. Treatment of hepatitis C and B virus infection with interferon. Rev Med Interne 2002;23(Suppl 4):459S-74S.
9. Gremion C, Cerny A, Hepatitis. C virus and the immune system: A concise review. Rev Med Virol 2005;15:236-268
10. Sene D, Touitou V, Bodaghi B, Saadoun D, Perlemuter G, Cassoux N, et al. Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 2007;13:3137-3140
11. Sylvestre DL, Disston AR, Bui DP. Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy. J Viral Hepat 2003;10:467-470
12. Kasahara A, Hiraide A, Tomita N, et al. Vogt-Koyanagi- Harada disease occurring during interferon alpha therapy for chronic hepatitis C. J Gastroenterol 2004;39:1106-1109